EndoByArtemis — Endometriosis & Chronic Pelvic Pain Symptom Tracker
endobyartemis.com
LaunchIndex first observed EndoByArtemis — Endometriosis & Chronic Pelvic Pain Symptom Tracker (endobyartemis.com) live on 9 September 2026. View its launch screenshot, category, technologies, and verification evidence.
A launch record built from evidence.
EndoByArtemis — Endometriosis & Chronic Pelvic Pain Symptom Tracker (endobyartemis.com) was first observed live on 9 September 2026.
EndoByArtemis is a symptom-tracking and education tool for endometriosis and chronic pelvic pain, built by a gynaecology resident for patients and clinicians to record patterns and prepare for appointments.
Its profile is classified as Saas within Health / Health and wellness. Verification detected Google Analytics.
What the launch signal contained.
- First observed live
- Previous state
- No prior non-live observation
- Last verified
- Canonical host
- endobyartemis.com
- Category
- Health / Health and wellness
- Website type
- Saas
- Observed title
- EndoByArtemis — Endometriosis & Chronic Pelvic Pain Symptom Tracker
- Observed description
- Track pelvic pain, heavy periods, pain with intercourse, and pain opening your bowels, whether it's linked to endometriosis, PCOS, or another cause, then turn months of entries into one clear picture for your next doctor's appointment. A femtech symptom tracker built by a gynaecology resident with a special interest in endometriosis, for patients anywhere. Join the waitlist.
- Detected technologies
- Google Analytics
- Screenshot captured
- Evidence source
- Browser observation · Local
- Evidence confidence
- 93%
- HTTP status
- 200
Is this your website?
Claim this profile to add verified owner information.
What do you make of this launch?
Vote on the site and leave a short note for other people exploring the new web.
Report an issueFlag spam, illegal or harmful content, or inaccurate information.
Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.
Join the discussion
Sign in with Google to vote or comment.
Sign in to participateComments
0 commentsBe the first to leave a useful observation.